# Genethon Signs Licensing Agreement With AskBio for the Development of an Investigational Gene Therapy for Pompe Disease
**Published:** 1/14/2026
**Category:** science
---
PARIS--(BUSINESS WIRE)--Genethon's agreement with AskBio, enables the development of a gene therapy for patients suffering from this particularly severe condition
---
*This article was automatically generated and curated by our AI news platform.*